Nine years after selling Medivation to Pfizer for $14 billion, David Hung, M.D., is going toe to toe with the New York ...

Despite an outcry from the biopharmaceutical industry, the U.K. government has kept the rebate rate under a national ...

With great power comes great responsibility, and Insulet, accordingly, is using its influence in the diabetes management ...

Hoping to gain an edge in the rapidly growing market are MilliporeSigma and Simtra BioPharma Solutions, which have forged a ...